Genetic testing company Artemis DNA reserves 100 VinFast EVs as part of the ESG program – QNT Press Release


Irvine, California, January 9, 2022 /PRNewswire/ – Artemis DNA, Inc. (“Artemis DNA” or “Company”), a full-service, accredited, highly complex clinical diagnostic laboratory company that provides proprietary next-generation sequencing (NGS) genetic and diagnostic tests through early disease detection “Personalized” medicine today announced that it has completed the booking of 100 electric vehicles for its sales fleet with Vietnamese electric vehicle manufacturer VinFast. These vehicles will include a mix of different models, including VF 6, VF 7, VF 8, and VF 9, which will be unveiled by automakers at the Consumer Electronics Show (CES) in 2022. Vegas, Nevada exist January 5, 2022.

The reservation of these vehicles makes Artemis DNA Vinfast the first corporate customer in the United States

The purchase of VinFast EV represents Artemis DNA’s continuous efforts to reduce the carbon footprint of its operations. The company has been actively pursuing its commitment to sound environmental, social and governance (ESG) programs, which include many climate-oriented goals. Artemis DNA is committed to becoming a leader in environmental management in the diagnostic and healthcare industries.

The company plans to start receiving VinFast EV from the fourth quarter of this year to support the company’s global expansion plan.

“The Artemis DNA team and I appreciate VinFast’s efforts to become an all-electric car manufacturer. We look forward to cooperating with VinFast and other Vingroup companies in the pursuit of creating a more environmentally friendly and environmentally friendly…

The full story can be found on Benzinga.com



Source link

Recommended For You

About the Author: News Center